Please use this identifier to cite or link to this item:
Title: Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa
Author: Belard, Sabine
Toepfner, Nicole
Capan-Melser, Mesküre
Mombo-Ngoma, Ghyslain
Zoleko-Manego, Rella
Groger, Mirjam
Matsiegui, Pierre-Blaise
Agnandji, Selidji Todagbe
Adegnika, Ayôla A.
González, Raquel
Kremsner, Peter G.
Menéndez, Clara
Ramharter, Michael
Berner, Reinhard
Keywords: Estreptococs
Medicaments antibacterians
Antibacterial agents
Pregnant women
Issue Date: 25-Nov-2015
Publisher: Nature Publishing Group
Abstract: Neonatal invasive disease due to Streptococcus agalactiae is life threatening and preventive strategies suitable for resource limited settings are urgently needed. Protective coverage of vaccine candidates based on capsular epitopes will relate to local epidemiology of S. agalactiae serotypes and successful management of critical infections depends on timely therapy with effective antibiotics. This is the first report on serotype distribution and antimicrobial susceptibility of S. agalactiae in pregnant women from a Central African region. Serotypes V, III, and Ib accounted for 88/109 (81%) serotypes and all isolates were susceptible to penicillin and clindamycin while 13% showed intermediate susceptibility to erythromycin.
Note: Reproducció del document publicat a:
It is part of: Scientific Reports, 2015, vol. 5, num. , p. 17281
Related resource:
ISSN: 2045-2322
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
belard2015_2029.pdf240.98 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons